For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section. n/a Confirmed The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Give P values as exact values whenever suitable.
For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated Our web collection on statistics for biologists contains articles on many of the points above.
Software and code
Policy information about availability of computer code
Data collection

Data analysis
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information. Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: 
Life sciences study design
All studies must disclose on these points even when the disclosure is negative.
Sample size
Data exclusions
Replication All data available upon request. Figure 1g : >50,000 cells counted for each sample. Figure 2a : >50,000 cells counted for each sample. Figure 2b : 20 schizonts counted for each biological replicate. Figure 2c : >500 late stages counted for each replicate Figure 2d : >1900 mean number of free merozoites counted per replicate The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided. Non-commercial antibodies: Primary antibodies mouse anti-CyRPA (8A7), mouse anti-RH5, mouse anti-RAP1 rabbit anti-RON4, rabbit anti-EBA175 and rabbit anti-GAP45(R728K) were provided by Prof. Alan Cowman at the Walter and Eliza Hall Institute of Medical Research. Rabbit anti-EXP2 was provided by Dr. Paul Gilson at the Burnet Institute. Rabbit anti-ERC and rabbit anti-GAPDH were provided by Prof. Leann Tilley at Bio21 Institute.
Methodology
Antibodies previously validated commercially or by the laboratories listed in peer reviewed publications (available in manuscript).
For growth assays: Cells were washed once in PBS, before staining in PBS + Ethidium bromide for 30 minutes. Cells were then washed twice with PBS before flow cytometry analysis. For invasion assays: To 50 microlitres of cells, 170 microlitres of PBS + Ethidium bromide was added. Cells were stained for 30 minutes in the dark before flow cytometry analysis.
